ERYTHROMYCIN

ERYTHROMYCIN was reported 18958 times

ERYTHROMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI FACTOR V ANTIBODY 20 0.7143
1 GRIP STRENGTH 123 0.5371
2 UMBILICAL ERYTHEMA 17 0.2787
3 SWOLLEN JOINT COUNT 57 0.2280
4 LUPUS VULGARIS 170 0.1349
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 75 0.1123
6 PORPHYRIA ACUTE 138 0.0962
7 DISLOCATION OF VERTEBRA 210 0.0920
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 190 0.0916
9 BLOODY DISCHARGE 101 0.0884
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 174 0.0869
11 X-RAY ABNORMAL 150 0.0838
12 SERONEGATIVE ARTHRITIS 94 0.0820
13 RETINITIS 133 0.0769
14 DEAFNESS PERMANENT 15 0.0765
15 INTERNATIONAL NORMALISED RATIO FLUCTUATION 148 0.0715
16 SWOLLEN JOINT COUNT INCREASED 170 0.0533
17 HYPHAEMA 26 0.0498
18 DRUG TOLERANCE DECREASED 140 0.0498
19 RHEUMATIC FEVER 221 0.0495
20 FACET JOINT SYNDROME 159 0.0488
21 BONE EROSION 160 0.0452
22 MONOCYTOSIS 27 0.0435
23 NECROSIS ISCHAEMIC 20 0.0434
24 RHEUMATOID FACTOR POSITIVE 225 0.0389
25 PNEUMOCOCCAL INFECTION 23 0.0389
26 BREAST CANCER STAGE III 247 0.0381
27 PERIORBITAL PAIN 32 0.0378
28 PERIPHERAL VENOUS DISEASE 152 0.0372
29 FAECAL VOLUME DECREASED 17 0.0354
30 DUODENAL ULCER PERFORATION 258 0.0347
31 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 18 0.0321
32 C-REACTIVE PROTEIN ABNORMAL 205 0.0319
33 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 224 0.0312
34 C-REACTIVE PROTEIN 28 0.0302
35 LYME DISEASE 99 0.0297
36 ALLERGIC OEDEMA 19 0.0293
37 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 31 0.0292
38 MEASLES 15 0.0278
39 MATERNAL EXPOSURE TIMING UNSPECIFIED 102 0.0271
40 SEPSIS NEONATAL 21 0.0259
41 HELICOBACTER INFECTION 247 0.0240
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 153 0.0235
43 EYELID PAIN 46 0.0226
44 INTRA-UTERINE DEATH 36 0.0224
45 HYPERPARATHYROIDISM SECONDARY 56 0.0223
46 PNEUMONIA STREPTOCOCCAL 24 0.0219
47 ENDOCRINE OPHTHALMOPATHY 19 0.0219
48 AUTOIMMUNE DISORDER 212 0.0217
49 NEPHROGENIC ANAEMIA 100 0.0216
50 WOUND INFECTION 235 0.0214
51 PYLORIC STENOSIS 18 0.0213
52 GRIP STRENGTH DECREASED 187 0.0212
53 REBOUND ACID HYPERSECRETION 64 0.0211
54 FOLLICULITIS 220 0.0210
55 MUSCLE INJURY 173 0.0209
56 BURSITIS 235 0.0193
57 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 24 0.0190
58 ULCERATIVE KERATITIS 52 0.0190
59 EXOSTOSIS 168 0.0184
60 LIP DRY 167 0.0184
61 PEMPHIGUS 227 0.0181
62 FORCED EXPIRATORY VOLUME DECREASED 51 0.0180
63 DEATH NEONATAL 25 0.0180
64 OTOTOXICITY 33 0.0178
65 PANCREATIC MASS 19 0.0178
66 HYPERCHOLESTEROLAEMIA 171 0.0177
67 SPONDYLITIS 63 0.0173
68 FOOT DEFORMITY 190 0.0171
69 EXPOSURE TO SARS-COV-2 29 0.0170
70 WALKING AID USER 111 0.0168
71 CORNEAL ABRASION 23 0.0168
72 HAND DEFORMITY 217 0.0165
73 JOINT RANGE OF MOTION DECREASED 221 0.0165
74 BRONCHIAL OBSTRUCTION 22 0.0157
75 LIVE BIRTH 129 0.0154
76 VERTIGO POSITIONAL 26 0.0148
77 PERICARDITIS 237 0.0141
78 STENOTROPHOMONAS INFECTION 19 0.0140
79 RED BLOOD CELL SEDIMENTATION RATE INCREASED 146 0.0132
80 IRON DEFICIENCY 58 0.0129
81 OLIGOHYDRAMNIOS 43 0.0129
82 LUPUS-LIKE SYNDROME 116 0.0128
83 OBSTRUCTION GASTRIC 15 0.0117
84 DEAFNESS NEUROSENSORY 37 0.0112
85 IRRITABLE BOWEL SYNDROME 240 0.0112
86 SYNOVITIS 200 0.0111
87 GLOSSODYNIA 243 0.0108
88 SCIATICA 173 0.0108
89 FOREIGN BODY SENSATION IN EYES 69 0.0108
90 FIBROMYALGIA 253 0.0104
91 COAGULATION TIME PROLONGED 16 0.0103
92 SPINAL FUSION SURGERY 41 0.0101
93 OBESITY 161 0.0101
94 DEAFNESS BILATERAL 17 0.0100
95 PULMONARY FIBROSIS 191 0.0099
96 PREMATURE RUPTURE OF MEMBRANES 24 0.0099
97 EYE PAIN 543 0.0096
98 WOUND 264 0.0094
99 END STAGE RENAL DISEASE 172 0.0094
100 RESPIRATORY ACIDOSIS 37 0.0094
101 LOWER RESPIRATORY TRACT CONGESTION 16 0.0094
102 ABDOMINAL MASS 25 0.0093
103 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 158 0.0093
104 TOXIC EPIDERMAL NECROLYSIS 139 0.0091
105 DIPLEGIA 18 0.0091
106 HEPATIC CIRRHOSIS 170 0.0090
107 HAEMORRHAGIC DIATHESIS 32 0.0090
108 LIVER INJURY 220 0.0090
109 JOINT DISLOCATION 94 0.0089
110 TYPE 2 DIABETES MELLITUS 297 0.0088
111 PRESCRIBED OVERDOSE 165 0.0085
112 MUSCLE CONTRACTURE 17 0.0084
113 MIXED LIVER INJURY 25 0.0083
114 TORSADE DE POINTES 65 0.0083
115 CHRONIC KIDNEY DISEASE 629 0.0083
116 BLEPHARITIS 32 0.0080
117 EYELID IRRITATION 20 0.0080
118 JAUNDICE CHOLESTATIC 28 0.0079
119 SYSTEMIC LUPUS ERYTHEMATOSUS 281 0.0079
120 EAR INFECTION 210 0.0079
121 HORDEOLUM 34 0.0079
122 SWELLING OF EYELID 49 0.0078
123 BRONCHITIS CHRONIC 19 0.0078
124 ARTHRITIS INFECTIVE 36 0.0078
125 LOWER LIMB FRACTURE 149 0.0077
126 PHOTOPHOBIA 145 0.0077
127 HIP ARTHROPLASTY 118 0.0077
128 OCULAR DISCOMFORT 86 0.0077
129 PSEUDOMEMBRANOUS COLITIS 17 0.0076
130 EYE INJURY 23 0.0076
131 STUPOR 24 0.0075
132 EYE INFECTION 83 0.0073
133 HYPERCAPNIA 22 0.0073
134 EYELID MARGIN CRUSTING 21 0.0073
135 THROMBOPHLEBITIS SUPERFICIAL 22 0.0073
136 CHEST INJURY 15 0.0072
137 WEIGHT FLUCTUATION 75 0.0072
138 PNEUMONIA FUNGAL 28 0.0071
139 DELIRIUM 245 0.0071
140 IMPAIRED HEALING 231 0.0070
141 RESPIRATORY RATE DECREASED 22 0.0070
142 OCULOGYRIC CRISIS 15 0.0070
143 SKIN WRINKLING 19 0.0070
144 BLOOD CHLORIDE DECREASED 18 0.0070
145 LOW BIRTH WEIGHT BABY 55 0.0069
146 WHEEZING 406 0.0068
147 PUSTULAR PSORIASIS 23 0.0067
148 IMPAIRED GASTRIC EMPTYING 91 0.0067
149 ECONOMIC PROBLEM 101 0.0067
150 ACCIDENTAL EXPOSURE 27 0.0065
151 MUCOUS STOOLS 32 0.0065
152 CONJUNCTIVAL HYPERAEMIA 23 0.0064
153 PREGNANCY 129 0.0064
154 MOUTH SWELLING 37 0.0064
155 EYE INFLAMMATION 61 0.0064
156 VASCULAR DEVICE INFECTION 29 0.0064
157 FREQUENT BOWEL MOVEMENTS 172 0.0064
158 DYSPHORIA 32 0.0063
159 INTRA-ABDOMINAL HAEMORRHAGE 15 0.0063
160 ABDOMINAL RIGIDITY 17 0.0063
161 MATERNAL EXPOSURE DURING PREGNANCY 558 0.0063
162 POTENTIATING DRUG INTERACTION 21 0.0063
163 PATHOGEN RESISTANCE 57 0.0062
164 LOWER RESPIRATORY TRACT INFECTION 283 0.0062
165 CAESAREAN SECTION 72 0.0062
166 OSTEOARTHRITIS 262 0.0062
167 CONGENITAL ANOMALY 47 0.0061
168 EYE DISCHARGE 63 0.0061
169 NIGHT SWEATS 193 0.0060
170 RESPIRATORY DISORDER 178 0.0059
171 PLATELET COUNT INCREASED 77 0.0059
172 CONTRAINDICATED PRODUCT ADMINISTERED 178 0.0059
173 BLOOD CHOLESTEROL INCREASED 274 0.0059
174 GESTATIONAL DIABETES 28 0.0059
175 DIVERTICULUM 41 0.0058
176 INFUSION SITE REACTION 17 0.0057
177 PLANTAR FASCIITIS 19 0.0057
178 KERATITIS 17 0.0056
179 BLISTER 314 0.0056
180 OEDEMA 303 0.0056
181 BLEPHAROSPASM 35 0.0056
182 EAR PAIN 108 0.0055
183 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 43 0.0055
184 CEREBRAL ATROPHY 22 0.0055
185 SKIN WARM 32 0.0055
186 SPUTUM DISCOLOURED 52 0.0055
187 EYE IRRITATION 314 0.0054
188 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 18 0.0054
189 APPETITE DISORDER 36 0.0054
190 CEREBRAL HAEMATOMA 18 0.0054
191 INFLAMMATORY BOWEL DISEASE 52 0.0053
192 SECRETION DISCHARGE 66 0.0053
193 ROAD TRAFFIC ACCIDENT 220 0.0053
194 ABORTION SPONTANEOUS 209 0.0052
195 KNEE ARTHROPLASTY 109 0.0052
196 ERYTHEMA OF EYELID 28 0.0052
197 DRUG INTOLERANCE 491 0.0051
198 ARTHROPATHY 282 0.0051
199 PSORIATIC ARTHROPATHY 205 0.0050
200 DISCOMFORT 305 0.0050
201 RESPIRATORY RATE INCREASED 44 0.0050
202 STEVENS-JOHNSON SYNDROME 110 0.0049
203 UMBILICAL HERNIA 23 0.0049
204 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
205 LABORATORY TEST ABNORMAL 145 0.0049
206 HYPOMANIA 18 0.0049
207 TENDERNESS 51 0.0049
208 TEARFULNESS 21 0.0049
209 WHITE BLOOD CELL COUNT INCREASED 187 0.0049
210 PRESCRIBED UNDERDOSE 97 0.0049
211 EAR PRURITUS 17 0.0048
212 ANAPHYLACTIC REACTION 267 0.0048
213 TRICUSPID VALVE INCOMPETENCE 38 0.0048
214 PERIORBITAL SWELLING 27 0.0048
215 RECTAL HAEMORRHAGE 205 0.0048
216 ATELECTASIS 46 0.0048
217 PREMATURE BABY 143 0.0047
218 COLITIS ULCERATIVE 211 0.0047
219 RHINITIS ALLERGIC 21 0.0047
220 OSTEOPOROSIS 194 0.0047
221 MATERNAL DRUGS AFFECTING FOETUS 36 0.0047
222 SUDDEN CARDIAC DEATH 16 0.0047
223 TUBULOINTERSTITIAL NEPHRITIS 87 0.0046
224 INJURY 324 0.0046
225 HYPOVENTILATION 15 0.0046
226 HIATUS HERNIA 59 0.0046
227 OCULAR HYPERAEMIA 216 0.0045
228 TYPE I HYPERSENSITIVITY 16 0.0045
229 CONJUNCTIVITIS 84 0.0045
230 DRUG-INDUCED LIVER INJURY 142 0.0045
231 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
232 HEPATIC NECROSIS 17 0.0045
233 EYE SWELLING 165 0.0044
234 ULCER HAEMORRHAGE 30 0.0044
235 ABNORMAL SENSATION IN EYE 19 0.0044
236 LUNG DISORDER 216 0.0044
237 MOBILITY DECREASED 316 0.0044
238 EXPOSURE DURING PREGNANCY 272 0.0044
239 DERMATITIS ALLERGIC 55 0.0044
240 STILLBIRTH 21 0.0043
241 CHOLECYSTITIS CHRONIC 29 0.0043
242 HYPOTONIA 43 0.0043
243 PATENT DUCTUS ARTERIOSUS 17 0.0043
244 THERAPEUTIC PRODUCT EFFECT DECREASED 191 0.0043
245 FACIAL PAIN 38 0.0043
246 SKIN NECROSIS 22 0.0042
247 INCREASED TENDENCY TO BRUISE 39 0.0042
248 JOINT STIFFNESS 111 0.0042
249 PURULENT DISCHARGE 18 0.0042
250 PIGMENTATION DISORDER 26 0.0042
251 SCOLIOSIS 26 0.0042
252 PHARYNGEAL SWELLING 41 0.0042
253 MYOSITIS 37 0.0041
254 EYE OPERATION 19 0.0041
255 ASTHMA 466 0.0041
256 GASTROINTESTINAL MOTILITY DISORDER 22 0.0041
257 AMNESIA 265 0.0041
258 LACRIMATION INCREASED 123 0.0041
259 LIVER FUNCTION TEST INCREASED 87 0.0040
260 ONYCHOMADESIS 17 0.0040
261 INFUSION RELATED REACTION 268 0.0040
262 LIVER DISORDER 178 0.0040
263 NASAL DRYNESS 25 0.0040
264 DRUG INTERACTION 631 0.0040
265 RENAL TUBULAR NECROSIS 39 0.0040
266 MUSCULOSKELETAL PAIN 208 0.0040
267 BREAST CANCER STAGE II 33 0.0040
268 PHARYNGEAL OEDEMA 61 0.0040
269 PARANASAL SINUS DISCOMFORT 15 0.0040
270 DERMATITIS CONTACT 45 0.0039
271 C-REACTIVE PROTEIN INCREASED 143 0.0039
272 BLOOD PRESSURE DIASTOLIC INCREASED 18 0.0039
273 SYNOVIAL CYST 18 0.0039
274 DIVERTICULUM INTESTINAL 17 0.0039
275 CONTUSION 374 0.0039
276 PANCREATITIS 205 0.0039
277 ONYCHOMYCOSIS 17 0.0039
278 PRODUCT USE COMPLAINT 61 0.0039
279 ILL-DEFINED DISORDER 235 0.0039
280 INFECTION 558 0.0039
281 RHINOVIRUS INFECTION 15 0.0039
282 SWELLING 360 0.0038
283 DISABILITY 76 0.0038
284 SEASONAL ALLERGY 54 0.0038
285 HYPERSENSITIVITY 704 0.0038
286 PRE-ECLAMPSIA 18 0.0038
287 AZOTAEMIA 15 0.0038
288 DYSLIPIDAEMIA 19 0.0037
289 CANDIDIASIS 15 0.0037
290 HYPERTRANSAMINASAEMIA 26 0.0037
291 HEPATIC ENZYME INCREASED 254 0.0037
292 GASTROINTESTINAL DISORDER 333 0.0037
293 RHABDOMYOLYSIS 154 0.0037
294 DRUG EXPOSURE DURING PREGNANCY 125 0.0037
295 RENAL CYST 29 0.0036
296 SPINAL OSTEOARTHRITIS 32 0.0036
297 STOMATITIS 220 0.0036
298 PHYSICAL DISABILITY 16 0.0036
299 ORAL PAIN 81 0.0036
300 RENAL FAILURE 479 0.0036
301 MYOPATHY 31 0.0036
302 SINUSITIS 367 0.0036
303 MITRAL VALVE INCOMPETENCE 40 0.0035
304 AORTIC VALVE INCOMPETENCE 15 0.0035
305 ELECTROCARDIOGRAM QT PROLONGED 126 0.0035
306 STAPHYLOCOCCAL INFECTION 115 0.0035
307 SARS-COV-2 TEST POSITIVE 46 0.0035
308 RENAL INJURY 103 0.0035
309 SLEEP DISORDER 243 0.0034
310 ROSACEA 16 0.0034
311 RASH PUSTULAR 25 0.0034
312 OSTEOPENIA 52 0.0034
313 MUSCULOSKELETAL CHEST PAIN 53 0.0034
314 MELANOCYTIC NAEVUS 15 0.0034
315 SENSITIVITY TO WEATHER CHANGE 18 0.0034
316 URTICARIA 570 0.0034
317 RENAL PAIN 36 0.0034
318 ERYSIPELAS 17 0.0034
319 PSEUDOMONAS INFECTION 29 0.0034
320 ABDOMINAL DISCOMFORT 567 0.0034
321 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 240 0.0034
322 NODULE 44 0.0034
323 INTRAOCULAR PRESSURE INCREASED 43 0.0034
324 CARDIAC MURMUR 29 0.0033
325 MUSCULOSKELETAL STIFFNESS 293 0.0033
326 RHEUMATOID ARTHRITIS 379 0.0033
327 MULTIPLE INJURIES 21 0.0033
328 ACUTE KIDNEY INJURY 510 0.0033
329 SWOLLEN TONGUE 104 0.0033
330 GASTROOESOPHAGEAL REFLUX DISEASE 268 0.0033
331 RASH VESICULAR 16 0.0033
332 INFLAMMATION 170 0.0033
333 POOR VENOUS ACCESS 34 0.0033
334 EAR DISORDER 15 0.0033
335 HYPERLIPIDAEMIA 39 0.0033
336 OBSTRUCTIVE AIRWAYS DISORDER 36 0.0032
337 DIABETIC NEUROPATHY 16 0.0032
338 CHOLESTASIS 62 0.0032
339 NAIL DISORDER 28 0.0032
340 ASPERGILLUS INFECTION 21 0.0032
341 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
342 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 153 0.0032
343 DRY MOUTH 258 0.0032
344 HEPATOMEGALY 31 0.0032
345 GASTRITIS 83 0.0032
346 PREMATURE DELIVERY 50 0.0031
347 FEELING HOT 192 0.0031
348 SKIN ATROPHY 18 0.0031
349 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
350 RALES 18 0.0031
351 HAEMODIALYSIS 26 0.0031
352 ASTHENOPIA 17 0.0031
353 FOETAL DEATH 16 0.0031
354 DRUG TOXICITY 42 0.0031
355 ARTHRITIS 241 0.0031
356 PNEUMONIA BACTERIAL 28 0.0030
357 THERAPY NON-RESPONDER 137 0.0030
358 BRONCHITIS 225 0.0030
359 GENERAL PHYSICAL HEALTH DETERIORATION 351 0.0030
360 DRUG LEVEL INCREASED 50 0.0030
361 INFUSION SITE SWELLING 19 0.0030
362 RENAL FAILURE CHRONIC 23 0.0030
363 PRODUCTIVE COUGH 142 0.0030
364 VENTRICULAR FIBRILLATION 33 0.0030
365 VENTRICULAR SEPTAL DEFECT 17 0.0030
366 SHOCK HAEMORRHAGIC 24 0.0029
367 PRODUCT PACKAGING ISSUE 28 0.0029
368 PULMONARY HAEMORRHAGE 23 0.0029
369 AMMONIA INCREASED 15 0.0029
370 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 16 0.0029
371 PHLEBITIS 15 0.0029
372 DERMATITIS BULLOUS 21 0.0029
373 ABDOMINAL PAIN UPPER 592 0.0029
374 INTRACRANIAL PRESSURE INCREASED 16 0.0029
375 HEART RATE ABNORMAL 16 0.0029
376 SINUS HEADACHE 17 0.0029
377 URINE OUTPUT DECREASED 25 0.0029
378 ANHEDONIA 75 0.0029
379 FRUSTRATION TOLERANCE DECREASED 23 0.0028
380 ARTHROPOD BITE 21 0.0028
381 VISUAL IMPAIRMENT 351 0.0028
382 PREMATURE LABOUR 16 0.0028
383 SLEEP APNOEA SYNDROME 54 0.0028
384 DYSPEPSIA 278 0.0028
385 HYPOAESTHESIA 419 0.0028
386 CARDIAC VALVE DISEASE 16 0.0028
387 VENTRICULAR EXTRASYSTOLES 29 0.0028
388 BRAIN OEDEMA 35 0.0028
389 NORMAL NEWBORN 15 0.0028
390 MOTOR DYSFUNCTION 28 0.0027
391 HYPERTRIGLYCERIDAEMIA 16 0.0027
392 OEDEMA PERIPHERAL 332 0.0027
393 CHOKING SENSATION 15 0.0027
394 IMPAIRED QUALITY OF LIFE 39 0.0027
395 IRON DEFICIENCY ANAEMIA 25 0.0027
396 COAGULOPATHY 45 0.0027
397 BODY TEMPERATURE INCREASED 55 0.0027
398 MUSCULAR WEAKNESS 306 0.0027
399 DRY EYE 134 0.0027
400 PRODUCT ADMINISTRATION INTERRUPTED 21 0.0027
401 BACK INJURY 29 0.0027
402 TREATMENT FAILURE 220 0.0027
403 NEUTROPHILIA 15 0.0026
404 ATRIAL FLUTTER 21 0.0026
405 MIGRAINE 251 0.0026
406 DYSTONIA 51 0.0026
407 CROHN'S DISEASE 18 0.0026
408 JOINT SWELLING 317 0.0026
409 RIB FRACTURE 54 0.0026
410 PRODUCT ADMINISTRATION ERROR 53 0.0026
411 EYE PRURITUS 88 0.0026
412 DRUG RESISTANCE 67 0.0026
413 LUNG INFILTRATION 23 0.0026
414 BLOOD SODIUM DECREASED 49 0.0026
415 ENTEROCOLITIS 15 0.0026
416 UPPER RESPIRATORY TRACT INFECTION 120 0.0026
417 HYPOGAMMAGLOBULINAEMIA 17 0.0026
418 PHARYNGITIS STREPTOCOCCAL 28 0.0026
419 GENERALISED OEDEMA 32 0.0026
420 LIP SWELLING 86 0.0026
421 THINKING ABNORMAL 48 0.0026
422 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 44 0.0026
423 TASTE DISORDER 52 0.0026
424 RASH MACULO-PAPULAR 57 0.0026
425 DYSPNOEA EXERTIONAL 96 0.0025
426 CANDIDA INFECTION 43 0.0025
427 SINUS TACHYCARDIA 36 0.0025
428 RESPIRATORY TRACT INFECTION 66 0.0025
429 PLEURISY 15 0.0025
430 BLOOD PRESSURE SYSTOLIC INCREASED 49 0.0025
431 ELECTROLYTE IMBALANCE 29 0.0025
432 SENSATION OF FOREIGN BODY 21 0.0025
433 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
434 PURPURA 22 0.0025
435 FOETAL GROWTH RESTRICTION 15 0.0025
436 GASTROENTERITIS 36 0.0025
437 ABDOMINAL PAIN 572 0.0025
438 VOMITING 1151 0.0024
439 CHEST PAIN 452 0.0024
440 CARDIOMEGALY 30 0.0024
441 BLOOD MAGNESIUM DECREASED 21 0.0024
442 MULTI-ORGAN FAILURE 42 0.0024
443 UPPER-AIRWAY COUGH SYNDROME 20 0.0024
444 AKATHISIA 33 0.0024
445 NECK PAIN 135 0.0024
446 SWELLING FACE 157 0.0024
447 GALLBLADDER DISORDER 43 0.0024
448 RASH 1042 0.0024
449 FOETAL EXPOSURE DURING PREGNANCY 194 0.0024
450 MASS 33 0.0024
451 VITAMIN D DEFICIENCY 23 0.0024
452 INTERSTITIAL LUNG DISEASE 114 0.0024
453 PHARYNGITIS 29 0.0023
454 HYPERTENSION 495 0.0023
455 EYE MOVEMENT DISORDER 16 0.0023
456 CONFUSIONAL STATE 375 0.0023
457 SNEEZING 52 0.0023
458 CHOLELITHIASIS 76 0.0023
459 STATUS EPILEPTICUS 26 0.0023
460 MEMORY IMPAIRMENT 316 0.0023
461 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 120 0.0023
462 BLOOD CREATINE PHOSPHOKINASE INCREASED 66 0.0023
463 EPILEPSY 70 0.0023
464 HEPATIC FAILURE 69 0.0023
465 OESOPHAGITIS 25 0.0023
466 VIRAL INFECTION 76 0.0023
467 MOUTH ULCERATION 48 0.0023
468 PULMONARY CONGESTION 30 0.0023
469 ATRIAL SEPTAL DEFECT 19 0.0023
470 RENAL FAILURE ACUTE 96 0.0023
471 DENTAL CARIES 25 0.0023
472 THROMBOTIC MICROANGIOPATHY 22 0.0023
473 DEAFNESS 59 0.0023
474 NEPHROPATHY 21 0.0022
475 NEUTROPHIL COUNT INCREASED 23 0.0022
476 GAIT INABILITY 75 0.0022
477 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
478 POST-TRAUMATIC STRESS DISORDER 15 0.0022
479 PERIPHERAL SWELLING 344 0.0022
480 HAEMODYNAMIC INSTABILITY 17 0.0022
481 EYE DISORDER 73 0.0022
482 COLD SWEAT 39 0.0022
483 UPPER LIMB FRACTURE 44 0.0022
484 OXYGEN SATURATION DECREASED 124 0.0022
485 CELLULITIS 111 0.0022
486 FOOD ALLERGY 17 0.0022
487 DIVERTICULITIS 61 0.0022
488 ACUTE HEPATIC FAILURE 30 0.0022
489 POOR QUALITY SLEEP 47 0.0022
490 INFUSION SITE PAIN 28 0.0022
491 SKIN DISORDER 72 0.0022
492 ANXIETY 613 0.0022
493 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
494 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
495 DEFORMITY 20 0.0021
496 VITREOUS FLOATERS 21 0.0021
497 DEPRESSION 485 0.0021
498 HYPOXIA 75 0.0021
499 ORAL CANDIDIASIS 28 0.0021
500 NASOPHARYNGITIS 391 0.0021
501 BIPOLAR DISORDER 23 0.0021
502 PNEUMONIA 684 0.0021
503 BLINDNESS 86 0.0021
504 PYREXIA 728 0.0021
505 LEUKOCYTOSIS 38 0.0021
506 TOOTHACHE 38 0.0021
507 BLOOD ALKALINE PHOSPHATASE INCREASED 52 0.0021
508 ACIDOSIS 16 0.0021
509 VISION BLURRED 287 0.0021
510 CORONARY ARTERY DISEASE 63 0.0021
511 ANGIOEDEMA 92 0.0021
512 SINUS CONGESTION 28 0.0021
513 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
514 RETINAL DETACHMENT 19 0.0021
515 RETCHING 44 0.0021
516 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
517 INTERVERTEBRAL DISC DEGENERATION 19 0.0021
518 BLOOD COUNT ABNORMAL 31 0.0020
519 HAEMOPTYSIS 57 0.0020
520 MULTIPLE ALLERGIES 16 0.0020
521 CYANOSIS 32 0.0020
522 DIARRHOEA HAEMORRHAGIC 19 0.0020
523 BODY TEMPERATURE DECREASED 20 0.0020
524 DRUG ERUPTION 36 0.0020
525 ARTERIOSCLEROSIS 19 0.0020
526 INFUSION SITE ERYTHEMA 17 0.0020
527 RESPIRATORY TRACT CONGESTION 32 0.0020
528 DEVICE RELATED INFECTION 31 0.0020
529 GASTROINTESTINAL INFECTION 18 0.0020
530 BLOOD GLUCOSE FLUCTUATION 22 0.0020
531 VENTRICULAR TACHYCARDIA 33 0.0020
532 RHINITIS 16 0.0020
533 ANURIA 17 0.0020
534 WEIGHT DECREASED 551 0.0020
535 CHEST DISCOMFORT 202 0.0020
536 JAUNDICE 53 0.0020
537 MALNUTRITION 22 0.0020
538 DECUBITUS ULCER 16 0.0020
539 TACHYCARDIA 174 0.0020
540 HEPATITIS 50 0.0020
541 EAR DISCOMFORT 20 0.0019
542 MUSCLE SPASMS 357 0.0019
543 RASH MACULAR 68 0.0019
544 DYSPHAGIA 184 0.0019
545 ILEUS 24 0.0019
546 CHOLECYSTITIS 23 0.0019
547 PELVIC FRACTURE 15 0.0019
548 GLAUCOMA 37 0.0019
549 INTENTIONAL PRODUCT USE ISSUE 168 0.0019
550 BLOOD PRESSURE FLUCTUATION 46 0.0019
551 TINNITUS 88 0.0019
552 EMOTIONAL DISORDER 59 0.0019
553 DYSPNOEA 1081 0.0019
554 CONDITION AGGRAVATED 580 0.0019
555 GAIT DISTURBANCE 365 0.0019
556 TOOTH INFECTION 25 0.0019
557 BLOOD ALBUMIN DECREASED 15 0.0019
558 OROPHARYNGEAL PAIN 175 0.0019
559 VASCULITIS 22 0.0019
560 EMPHYSEMA 19 0.0019
561 PARAESTHESIA 296 0.0019
562 COUGH 526 0.0019
563 PULMONARY HYPERTENSION 39 0.0019
564 RHINORRHOEA 121 0.0019
565 MEDICATION ERROR 104 0.0019
566 ROTATOR CUFF SYNDROME 24 0.0019
567 INJECTION SITE EXTRAVASATION 23 0.0019
568 CYST 23 0.0019
569 ALOPECIA 363 0.0018
570 RESPIRATORY DISTRESS 51 0.0018
571 HAEMORRHOIDS 36 0.0018
572 MYOCARDIAL ISCHAEMIA 21 0.0018
573 POST PROCEDURAL INFECTION 15 0.0018
574 DECREASED APPETITE 426 0.0018
575 HEPATOCELLULAR INJURY 26 0.0018
576 DRUG DISPENSING ERROR 28 0.0018
577 PNEUMOTHORAX 29 0.0018
578 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0018
579 ASPIRATION 20 0.0018
580 EOSINOPHILIA 32 0.0018
581 ERYTHEMA MULTIFORME 17 0.0018
582 SEROTONIN SYNDROME 35 0.0018
583 PETECHIAE 19 0.0018
584 CIRCULATORY COLLAPSE 31 0.0018
585 SINUS DISORDER 36 0.0018
586 SEPTIC SHOCK 79 0.0018
587 INCONTINENCE 19 0.0018
588 HEPATOTOXICITY 40 0.0018
589 LIVER FUNCTION TEST ABNORMAL 52 0.0018
590 GOUT 32 0.0018
591 LYMPHADENOPATHY 63 0.0018
592 LOCALISED INFECTION 43 0.0018
593 GASTROENTERITIS VIRAL 32 0.0018
594 HEART RATE IRREGULAR 40 0.0018
595 TOOTH ABSCESS 18 0.0018
596 SEPSIS 197 0.0018
597 TACHYPNOEA 24 0.0018
598 ERECTILE DYSFUNCTION 45 0.0018
599 PAIN IN EXTREMITY 515 0.0017
600 TARDIVE DYSKINESIA 49 0.0017
601 TREATMENT NONCOMPLIANCE 95 0.0017
602 HYPOKALAEMIA 80 0.0017
603 PARAESTHESIA ORAL 25 0.0017
604 DIARRHOEA 1110 0.0017
605 HYPERKALAEMIA 60 0.0017
606 PRURITUS 657 0.0017
607 THROMBOCYTOPENIA 191 0.0017
608 ALTERED STATE OF CONSCIOUSNESS 37 0.0017
609 SPLENOMEGALY 20 0.0017
610 SMALL INTESTINAL OBSTRUCTION 21 0.0017
611 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
612 THROAT TIGHTNESS 46 0.0017
613 SQUAMOUS CELL CARCINOMA 16 0.0017
614 WEIGHT INCREASED 380 0.0017
615 ABDOMINAL DISTENSION 177 0.0017
616 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
617 BLOOD IRON DECREASED 20 0.0017
618 NASAL CONGESTION 99 0.0017
619 INSOMNIA 448 0.0017
620 TENDONITIS 26 0.0017
621 INTESTINAL OBSTRUCTION 63 0.0017
622 ACCIDENTAL OVERDOSE 61 0.0017
623 ACUTE RESPIRATORY FAILURE 32 0.0017
624 NAUSEA 1316 0.0017
625 DEVICE USE ISSUE 29 0.0017
626 VISUAL ACUITY REDUCED 55 0.0017
627 FUNGAL INFECTION 55 0.0016
628 CARPAL TUNNEL SYNDROME 23 0.0016
629 ARTHRALGIA 682 0.0016
630 MALAISE 719 0.0016
631 ADVERSE DRUG REACTION 147 0.0016
632 EYELID OEDEMA 19 0.0016
633 PRODUCT USE IN UNAPPROVED INDICATION 405 0.0016
634 TOOTH FRACTURE 18 0.0016
635 COELIAC DISEASE 16 0.0016
636 DIZZINESS 810 0.0016
637 LIGAMENT SPRAIN 16 0.0016
638 PNEUMONITIS 44 0.0016
639 BLOOD UREA INCREASED 27 0.0016
640 SKIN INFECTION 18 0.0016
641 FLANK PAIN 15 0.0016
642 DYSKINESIA 65 0.0016
643 HYPOTHYROIDISM 51 0.0016
644 BODY HEIGHT DECREASED 17 0.0016
645 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 87 0.0016
646 FOOT FRACTURE 30 0.0016
647 DECREASED ACTIVITY 17 0.0016
648 DRY THROAT 16 0.0016
649 DYSPHONIA 92 0.0016
650 ULCER 25 0.0016
651 ADRENAL INSUFFICIENCY 19 0.0016
652 METABOLIC ACIDOSIS 50 0.0016
653 RESPIRATORY FAILURE 114 0.0016
654 CATARACT 93 0.0016
655 PLEURAL EFFUSION 95 0.0016
656 SENSORY DISTURBANCE 25 0.0016
657 PANCREATITIS ACUTE 35 0.0016
658 INTERVERTEBRAL DISC PROTRUSION 34 0.0016
659 LIMB DISCOMFORT 48 0.0015
660 RESTLESS LEGS SYNDROME 28 0.0015
661 HAEMATEMESIS 39 0.0015
662 HEART RATE INCREASED 152 0.0015
663 EXTRAPYRAMIDAL DISORDER 38 0.0015
664 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
665 ALANINE AMINOTRANSFERASE INCREASED 93 0.0015
666 LIMB INJURY 41 0.0015
667 RASH GENERALISED 39 0.0015
668 BACTERIAL INFECTION 28 0.0015
669 SALIVARY HYPERSECRETION 15 0.0015
670 BLINDNESS UNILATERAL 21 0.0015
671 CARDIOMYOPATHY 22 0.0015
672 ASPARTATE AMINOTRANSFERASE INCREASED 79 0.0015
673 RASH ERYTHEMATOUS 71 0.0015
674 BACK PAIN 345 0.0015
675 TRANSIENT ISCHAEMIC ATTACK 50 0.0015
676 ASTHENIA 557 0.0015
677 SHOCK 34 0.0015
678 EYELID PTOSIS 15 0.0015
679 RASH PRURITIC 80 0.0015
680 BASAL CELL CARCINOMA 23 0.0015
681 GASTRIC ULCER 28 0.0015
682 HAEMATOCHEZIA 81 0.0015
683 CARDIAC ARREST 121 0.0015
684 EMOTIONAL DISTRESS 177 0.0015
685 LETHARGY 84 0.0015
686 HYPERHIDROSIS 188 0.0015
687 HEPATIC STEATOSIS 27 0.0014
688 POLLAKIURIA 60 0.0014
689 ARRHYTHMIA 68 0.0014
690 HEADACHE 900 0.0014
691 BONE DISORDER 26 0.0014
692 EYE HAEMORRHAGE 19 0.0014
693 FACE OEDEMA 24 0.0014
694 BLOOD CALCIUM DECREASED 16 0.0014
695 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
696 WRIST FRACTURE 17 0.0014
697 DYSURIA 52 0.0014
698 PAIN IN JAW 40 0.0014
699 DYSARTHRIA 53 0.0014
700 CHILLS 165 0.0014
701 BRONCHOSPASM 20 0.0014
702 RESTLESSNESS 51 0.0014
703 SKIN ULCER 36 0.0014
704 DIPLOPIA 36 0.0014
705 SKIN LESION 38 0.0014
706 MYELODYSPLASTIC SYNDROME 20 0.0014
707 FATIGUE 1075 0.0014
708 ABSCESS 22 0.0014
709 URINARY TRACT INFECTION 235 0.0014
710 BLOOD BILIRUBIN INCREASED 37 0.0014
711 TOOTH EXTRACTION 17 0.0014
712 BLOOD POTASSIUM DECREASED 41 0.0014
713 ADVERSE REACTION 18 0.0014
714 ANKLE FRACTURE 21 0.0014
715 INFLUENZA 151 0.0014
716 HALLUCINATION 102 0.0014
717 LUNG INFECTION 21 0.0014
718 ERYTHEMA 276 0.0013
719 MIDDLE INSOMNIA 25 0.0013
720 RENAL IMPAIRMENT 112 0.0013
721 PHOTOSENSITIVITY REACTION 22 0.0013
722 SKIN DISCOLOURATION 61 0.0013
723 HYPOAESTHESIA ORAL 20 0.0013
724 PALPITATIONS 155 0.0013
725 PALLOR 36 0.0013
726 PAIN 810 0.0013
727 ATRIAL FIBRILLATION 128 0.0013
728 CHOLECYSTECTOMY 15 0.0013
729 PERIPHERAL COLDNESS 18 0.0013
730 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
731 MYALGIA 222 0.0013
732 RASH PAPULAR 29 0.0013
733 CONSTIPATION 282 0.0013
734 BACK DISORDER 21 0.0013
735 HYPERGLYCAEMIA 47 0.0013
736 TREMOR 214 0.0013
737 DERMATITIS 27 0.0013
738 LOSS OF CONSCIOUSNESS 164 0.0013
739 UNRESPONSIVE TO STIMULI 33 0.0013
740 DEEP VEIN THROMBOSIS 83 0.0013
741 PULMONARY MASS 19 0.0013
742 PRESYNCOPE 31 0.0013
743 ILLNESS 131 0.0013
744 COVID-19 PNEUMONIA 15 0.0013
745 OSTEOMYELITIS 23 0.0013
746 FEAR 34 0.0013
747 LOCAL SWELLING 22 0.0013
748 HAEMATURIA 43 0.0013
749 PRODUCT USE ISSUE 235 0.0012
750 MOVEMENT DISORDER 40 0.0012
751 BRADYCARDIA 66 0.0012
752 PNEUMONIA ASPIRATION 31 0.0012
753 INFLUENZA LIKE ILLNESS 102 0.0012
754 APATHY 18 0.0012
755 UNDERDOSE 90 0.0012
756 NO THERAPEUTIC RESPONSE 15 0.0012
757 ADVERSE EVENT 113 0.0012
758 ABDOMINAL PAIN LOWER 31 0.0012
759 HEART RATE DECREASED 43 0.0012
760 COGNITIVE DISORDER 57 0.0012
761 MUSCULOSKELETAL DISCOMFORT 21 0.0012
762 DISEASE RECURRENCE 58 0.0012
763 HERPES ZOSTER 70 0.0012
764 PARANOIA 21 0.0012
765 JOINT INJURY 26 0.0012
766 HYPERCALCAEMIA 15 0.0012
767 TOOTH DISORDER 27 0.0012
768 DEHYDRATION 160 0.0012
769 RED BLOOD CELL COUNT DECREASED 34 0.0012
770 MENTAL STATUS CHANGES 33 0.0012
771 URINARY INCONTINENCE 35 0.0012
772 MELAENA 26 0.0012
773 LEUKOPENIA 59 0.0012
774 CHOKING 23 0.0012
775 EATING DISORDER 25 0.0012
776 OSTEONECROSIS OF JAW 29 0.0012
777 SCAR 20 0.0012
778 ANOREXIA 15 0.0012
779 EPISTAXIS 87 0.0012
780 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
781 COLITIS 44 0.0012
782 SURGERY 68 0.0012
783 HAEMATOCRIT DECREASED 23 0.0012
784 CARDIAC FAILURE CONGESTIVE 93 0.0012
785 PROTEINURIA 22 0.0012
786 THERAPY PARTIAL RESPONDER 18 0.0012
787 ANGINA PECTORIS 33 0.0012
788 POST PROCEDURAL COMPLICATION 22 0.0011
789 PANCYTOPENIA 64 0.0011
790 BURNING SENSATION 80 0.0011
791 BLOOD PRESSURE INCREASED 174 0.0011
792 HALLUCINATION, AUDITORY 18 0.0011
793 PERICARDIAL EFFUSION 26 0.0011
794 ANAEMIA 214 0.0011
795 SYNCOPE 112 0.0011
796 QUALITY OF LIFE DECREASED 15 0.0011
797 OFF LABEL USE 978 0.0011
798 DRY SKIN 149 0.0011
799 CHROMATURIA 25 0.0011
800 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
801 SKIN EXFOLIATION 93 0.0011
802 ENCEPHALOPATHY 27 0.0011
803 HYPOPHAGIA 28 0.0011
804 ORTHOSTATIC HYPOTENSION 19 0.0011
805 HYPOTENSION 218 0.0011
806 DRUG EFFECT INCOMPLETE 39 0.0011
807 PULMONARY EMBOLISM 102 0.0011
808 IMMUNODEFICIENCY 16 0.0011
809 HEAD DISCOMFORT 19 0.0011
810 BLOOD CREATININE INCREASED 70 0.0011
811 BLOOD PRESSURE DECREASED 71 0.0011
812 FALL 355 0.0011
813 DIABETES MELLITUS 81 0.0011
814 HEMIPARESIS 18 0.0011
815 NEUROPATHY PERIPHERAL 101 0.0011
816 TOOTH LOSS 22 0.0011
817 ABNORMAL BEHAVIOUR 42 0.0011
818 FRACTURE 20 0.0011
819 GASTRIC DISORDER 36 0.0010
820 URINARY RETENTION 35 0.0010
821 BLOOD POTASSIUM INCREASED 17 0.0010
822 PANIC ATTACK 38 0.0010
823 HALLUCINATION, VISUAL 22 0.0010
824 CYSTITIS 33 0.0010
825 FEEDING DISORDER 21 0.0010
826 CONVULSION 59 0.0010
827 HYPOGLYCAEMIA 50 0.0010
828 SPEECH DISORDER 54 0.0010
829 BALANCE DISORDER 89 0.0010
830 NEURALGIA 25 0.0010
831 PULMONARY OEDEMA 46 0.0010
832 APHASIA 31 0.0010
833 BONE DENSITY DECREASED 32 0.0010
834 BRAIN FOG 16 0.0010
835 UNEVALUABLE EVENT 77 0.0010
836 HEAD INJURY 32 0.0010
837 PRODUCT PRESCRIBING ISSUE 22 0.0010
838 COMA 48 0.0010
839 THIRST 18 0.0010
840 INCREASED APPETITE 19 0.0010
841 NERVOUS SYSTEM DISORDER 31 0.0010
842 HEPATIC FUNCTION ABNORMAL 37 0.0010
843 MENTAL DISORDER 43 0.0010
844 CARDIOVASCULAR DISORDER 25 0.0010
845 HAEMOGLOBIN DECREASED 101 0.0010
846 SUICIDAL IDEATION 90 0.0010
847 ERUCTATION 19 0.0010
848 SEIZURE 113 0.0010
849 PRURITUS GENERALISED 21 0.0010
850 PRODUCT DOSE OMISSION ISSUE 285 0.0010
851 AGITATION 71 0.0010
852 DELUSION 15 0.0010
853 PSYCHOMOTOR HYPERACTIVITY 16 0.0010
854 DIABETIC KETOACIDOSIS 23 0.0010
855 HYPOCALCAEMIA 18 0.0010
856 SPINAL FRACTURE 19 0.0009
857 DEPRESSED MOOD 50 0.0009
858 FEELING JITTERY 18 0.0009
859 BONE MARROW FAILURE 19 0.0009
860 FEELING COLD 26 0.0009
861 IRRITABILITY 56 0.0009
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 167 0.0009
863 FAECES DISCOLOURED 20 0.0009
864 GASTROINTESTINAL HAEMORRHAGE 77 0.0009
865 ASCITES 27 0.0009
866 PERITONITIS 19 0.0009
867 ACUTE MYOCARDIAL INFARCTION 27 0.0009
868 AGRANULOCYTOSIS 17 0.0009
869 METASTASES TO BONE 15 0.0009
870 THROAT IRRITATION 41 0.0009
871 MULTIPLE FRACTURES 15 0.0009
872 RESPIRATORY ARREST 25 0.0009
873 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
874 HYPOACUSIS 39 0.0009
875 FLUID RETENTION 46 0.0009
876 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
877 HIP FRACTURE 29 0.0009
878 AGGRESSION 45 0.0009
879 ECZEMA 47 0.0009
880 NIGHTMARE 31 0.0009
881 BLOOD GLUCOSE DECREASED 43 0.0009
882 COVID-19 157 0.0009
883 SOMNOLENCE 180 0.0009
884 ANAPHYLACTIC SHOCK 23 0.0009
885 VERTIGO 54 0.0009
886 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
887 PRODUCT PRESCRIBING ERROR 21 0.0009
888 PSYCHOTIC DISORDER 26 0.0009
889 DERMATITIS ATOPIC 46 0.0009
890 CARDIAC FAILURE 70 0.0009
891 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
892 ORAL HERPES 17 0.0009
893 THERAPY INTERRUPTED 62 0.0009
894 RENAL DISORDER 40 0.0009
895 DISTURBANCE IN ATTENTION 46 0.0009
896 HAEMATOMA 22 0.0008
897 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
898 DRUG INEFFECTIVE 1116 0.0008
899 HOSPITALISATION 130 0.0008
900 MUSCLE TWITCHING 19 0.0008
901 HYPONATRAEMIA 46 0.0008
902 KIDNEY INFECTION 16 0.0008
903 EXPOSURE VIA SKIN CONTACT 21 0.0008
904 BONE PAIN 47 0.0008
905 HYPERSOMNIA 23 0.0008
906 CRYING 29 0.0008
907 PLATELET COUNT DECREASED 85 0.0008
908 PLASMA CELL MYELOMA 31 0.0008
909 INTENTIONAL PRODUCT MISUSE 69 0.0008
910 MYOCARDIAL INFARCTION 136 0.0008
911 THERAPEUTIC RESPONSE DECREASED 47 0.0008
912 PSORIASIS 101 0.0008
913 INTENTIONAL DOSE OMISSION 22 0.0008
914 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 155 0.0008
915 NEPHROLITHIASIS 35 0.0008
916 AGEUSIA 19 0.0008
917 FLATULENCE 43 0.0008
918 DISORIENTATION 30 0.0008
919 IMPAIRED WORK ABILITY 16 0.0007
920 FULL BLOOD COUNT DECREASED 15 0.0007
921 FEMUR FRACTURE 23 0.0007
922 FEELING ABNORMAL 177 0.0007
923 FEBRILE NEUTROPENIA 49 0.0007
924 APPLICATION SITE PAIN 16 0.0007
925 SEDATION 19 0.0007
926 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
927 MENTAL IMPAIRMENT 17 0.0007
928 CEREBROVASCULAR ACCIDENT 118 0.0007
929 THROMBOSIS 56 0.0007
930 MOOD SWINGS 22 0.0007
931 MUCOSAL INFLAMMATION 18 0.0007
932 DEMENTIA 19 0.0007
933 HAEMORRHAGE 71 0.0007
934 TOXICITY TO VARIOUS AGENTS 113 0.0007
935 NERVOUSNESS 35 0.0007
936 CARDIO-RESPIRATORY ARREST 28 0.0007
937 NEUTROPHIL COUNT DECREASED 27 0.0007
938 EXPIRED PRODUCT ADMINISTERED 22 0.0007
939 MOOD ALTERED 18 0.0007
940 ABNORMAL DREAMS 18 0.0007
941 PROCEDURAL PAIN 18 0.0006
942 DYSGEUSIA 48 0.0006
943 CARDIAC DISORDER 60 0.0006
944 OSTEONECROSIS 21 0.0006
945 NEUTROPENIA 85 0.0006
946 VAGINAL HAEMORRHAGE 27 0.0006
947 ANGER 21 0.0006
948 INCORRECT DRUG ADMINISTRATION DURATION 17 0.0006
949 WHITE BLOOD CELL COUNT DECREASED 65 0.0006
950 PRODUCT COMPLAINT 15 0.0006
951 HOT FLUSH 44 0.0006
952 FLUSHING 58 0.0006
953 PRODUCT QUALITY ISSUE 77 0.0006
954 SKIN BURNING SENSATION 40 0.0006
955 DYSSTASIA 16 0.0005
956 DRUG EFFECT DECREASED 29 0.0005
957 NEEDLE ISSUE 15 0.0005
958 CEREBRAL HAEMORRHAGE 18 0.0005
959 LACTIC ACIDOSIS 16 0.0005
960 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
961 DISEASE PROGRESSION 57 0.0005
962 ACNE 36 0.0005
963 BLOOD GLUCOSE INCREASED 87 0.0005
964 INJECTION SITE BRUISING 35 0.0004
965 NEOPLASM PROGRESSION 15 0.0004
966 INJECTION SITE REACTION 29 0.0004
967 SKIN IRRITATION 19 0.0004
968 PRODUCT DOSE OMISSION 27 0.0004
969 OVERDOSE 89 0.0004
970 DRUG WITHDRAWAL SYNDROME 36 0.0004
971 INCORRECT DOSE ADMINISTERED 88 0.0004
972 DEVICE ISSUE 34 0.0004
973 INJECTION SITE ERYTHEMA 47 0.0004
974 SUICIDE ATTEMPT 22 0.0004
975 THERAPY CESSATION 18 0.0004
976 DEVICE DISLOCATION 15 0.0003
977 DEATH 297 0.0003
978 COMPLETED SUICIDE 28 0.0003
979 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
980 PRODUCT STORAGE ERROR 28 0.0003
981 NEOPLASM MALIGNANT 21 0.0003
982 NO ADVERSE EVENT 55 0.0003
983 DRUG DOSE OMISSION 50 0.0003
984 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
985 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
986 BREAST CANCER 25 0.0003
987 PRODUCT SUBSTITUTION ISSUE 15 0.0003
988 INJECTION SITE PAIN 79 0.0003
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
990 DRUG DEPENDENCE 37 0.0002
991 INJECTION SITE PRURITUS 15 0.0002
992 INJECTION SITE SWELLING 15 0.0002